Clinical Decision Support System Market – Supporting Better Health
Clinical decision support system is IT-based tool that assists doctors and nurses by providing actionable inputs about patient for enhancement of health outcome of patient. This system provides customized, patient specific clinical information, which improves quality of care. Various tools in the clinical decision support system include computerized alerts and reminders to care providers and patients, clinical guidelines and protocols, condition-specific order sets, focused patient data reports and summaries, smart documentation templates, diagnostic support, multipatient monitors and dashboards, contextually relevant reference information, and predictive and retrospective analytics.
Clinical decision support system provide different benefits such as reduction in clinical error and adverse events, improved quality of healthcare service, increased efficiency and reduction in overall healthcare cost. Clinical decision support system is one of emerging healthcare technology designed to improve clinical decision making, this system could address the problem of clinical information burden faced by healthcare providers in routine decision making. Clinical decision support system provides a platform for integrating evidence-based knowledge into care delivery that improves clinical outcome.
The global clinical decision support system market size was valued at US$ 767.4 million in 2017, and is expected to witness a CAGR of 11.69 % over the forecast period (2018 – 2026).
Figure 1. Global Clinical Decision Support System Market Value (US$ Mn), by Region, 2017
Source – Coherent Market Insights Report
Various benefits provided by the CDSS to drive growth of the clinical decision support system market
According to report by Healthcare Information and Management Systems Society in 2011, Clinical decision support system has been proved to be helpful in reducing number of days at hospitals, reduction in hospital readmissions, preventing the incidence of medical error, and adverse events due to clinical decision. Advantages offered by clinical decision support system are expected to increase its adoption among end users, which in turn is driving growth for the clinical decision support system market.
Developed economy such as the U.S. invests US$ 10,000 per person annually, according to data given by the Organization of Economic Cooperation and Development in 2017. Significant cost is incurred due to various medical errors and adverse drug events. According to study published in the BMJ, in 2016, more than 250,000 people die annually due to medical errors in the U.S. Significant number of deaths and extra cost on hospital stay can be saved by integrating CDSS in the healthcare provider infrastructure.
Legislations such as Act Health Information Technology for Economic and Clinical Health Act (HITECH), 2009 has compelled the adoption and meaningful use of clinical decision support systems and other health IT platforms by 2015. Failing to implement this resulted in reduction in Medicare reimbursements in the following year (after 2015).
Figure 2. Global Clinical Decision Support System Market Segmentation
Source – Coherent Market Insights Report
Increasing chronic disease prevalence worldwide to propel growth of the clinical decision support system market
Increasing prevalence of the chronic disease such as cancer, diabetes, and cardiovascular disease worldwide is propelling demand for its accurate diagnosis, treatment plan, and continuous care. According to the data published by American Heart Association, in 2016, annual cost of cardiovascular disease and stroke in 2011 – 2012 was US$ 193.1 billion in medical care and about US$ 123 billion in lost productivity from premature death. This cost can be reduced by adopting clinical decision support system, which could prevent and control major risk factors for CVD such as hypertension, hypercholesterolemia, and diabetes.
However, CDSS system has few limitation in its operation, which may hinder growth of the clinical decision support system market.
Key players are launching new products, which is expected to propel growth of the clinical decision support system market. In February 2018, the US Food and Drug Administration (FDA) granted marketing clearance for Viz.AI's Contact application. It is first Artificial Intelligence-based Clinical Decision Support (CDS) solution approved in the U.S. Integration of the Electronic Health Record(EHR), Computerized Physician Order Entry(CPOE) into CDSS by key players are expected to increase the adoption of the CDSS system, in turn driving growth of the clinical decision support system market. Furthermore, key players are entering into licensing deals with leading hospitals and healthcare groups to expand their consumer base and improve revenue prospects.
Key players operating in the clinical decision support system market include Cerner Corporation, Allscripts Healthcare Solutions, Inc., IBM Watson Health, GE Healthcare, Change Healthcare, Zynx Health, Carestream Health Inc., First Databank, Inc., NextGen Healthcare Information Systems, Agfa Healthcare, Medical Information Technology Inc., Athena Health, Wolters Kluwer NU, Siemens Healthineers, and Philips Healthcare.
Clinical Decision Support System (CDSS) is healthcare IT solution that provides evidence-based information to provide optimum care to patient. Clinical decision support system assist healthcare providers, by analyzing of patient data and using that information to aid in diagnosis of specific disease and treatment plan for same. Information input offered by CDSS to clinicians and primary care providers helps to improve the quality of the care by reducing drug overdose, drug interaction, adverse events, and assisting in diagnosis.
Major driver for growth of the clinical decision support system market is various benefits offered by the CDSS in both inpatient settings, ambulatory settings, and clinics. Medical error is one of the significant contributor to cause of death worldwide. According to data published by Centre for Disease Control and Prevention (CDC), 2013, more than 150,000 deaths are reported annually in the U.S. due to medical error (ADR, wrong diagnosis, prescription error)
According to World Health Organization (WHO) report, in 2017, medication error costs US$ 42 billion annually worldwide. An estimated 43 million patient safety incidence occur annually and around 1 in 10 patient get harmed due to medication error while receiving healthcare. These incidence of medication error could be addressed with use of CDSS. Increasing prevalence of chronic disease is another driver for wide adoption of CDSS. According to WHO Factsheet, around 73% of global deaths are expected to be from chronic disease by 2020.
Key features of the study:
“*” marked represents similar segmentation in other categories in the respective section.
Joining thousands of companies around the world committed to making the Excellent Business Solutions.View All Our Clients